Advancing clinical research

We are committed to advancing specialty care and treatment of rare diseases, with a strong focus on the following areas

Transparency, access and collaboration

Driving scientific transparency

Scientific transparency

Expanded access at Alfasigma

Expanded access

External sponsored research

Sponsored research

Our development programmes have the potential to deliver meaningful breakthroughs for patients, positioning us at the forefront of innovation. We continue to invest in strengthening and expanding our pipeline to serve patients worldwide